← SynDRA
PF-06380101
SynDRA canonical compound SYN1491110 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | TUBB |
|---|
| Mechanism of action | tubulin inhibitor |
|---|
| Indication | breast cancer |
|---|
| Disease area | oncology |
|---|
Cross-references
Synonyms
- Auristatin 0101
- Q8020AX34E
- AUR-0101
- UNII-Q8020AX34E
- RefChem:202561
- QAAFNSMAIAVCHE-BZLYQNAUSA-N
- orb1706815
- SCHEMBL14936149
- C39H62N6O6S
- EX-A15119
- MFCD28385873
- AKOS040742399
- CS-3706
- NCGC00485972-01
- DA-66621
- HY-12522
- MS-31297
- F85106
- T16490
- 3WD
- 2-methyl-L-alanyl-N-[(3R,4S,5S)-3-methoxy-1-{(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-{[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino}propyl]pyrrolidin-1-yl}-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide
Look up PF-06380101 in the interactive SynDRA portal →